Systematic review and meta-analysis on the association between phthalates exposure and insulin resistance.


Journal

Environmental science and pollution research international
ISSN: 1614-7499
Titre abrégé: Environ Sci Pollut Res Int
Pays: Germany
ID NLM: 9441769

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 24 08 2018
accepted: 24 01 2019
pubmed: 9 2 2019
medline: 17 5 2019
entrez: 9 2 2019
Statut: ppublish

Résumé

This study aims to provide an overview of human studies on the association of exposure to phthalates and insulin resistance. We systematically searched human studies available until 15 January 2018.We conducted a literature search in Scopus, ISI Web of Science, PubMed, Google Scholar, and Cochrane Collaboration. We used the following keywords to identify relevant articles: "phthalate", "phthalate ester", "metabolic syndrome", "insulin resistance", "glucose intolerance", and "diabetes". For analyzing data, we conducted meta-analysis using the Stata software. We appraised each study to examine the sources of heterogeneity, including difference in clinical outcomes and exposure measurements. To determine the robustness and whether some of the factors have the highest impact on the results of the present meta-analysis, several sensitivity analyses were conducted. Sensitivity analysis showed that by removing studies with the highest weight and age groups, no change was observed in heterogeneity. Moreover, with excluding the study conducted in Europe, the results remained unchanged and constant. In addition, the funnel plot and Egger's tests were executed to access publication bias. Both the funnel plots and Egger's test did not show any evidence of publication bias (P = 0.31). In the random effects meta-analysis of all studies (n = 8), the pooled correlation coefficient between phthalate exposure and HOMA-IR was 0.10 (95% CI; 0.07-0.12, P < 0.001), with significant heterogeneity (P < 0.001, I

Identifiants

pubmed: 30734259
doi: 10.1007/s11356-019-04373-1
pii: 10.1007/s11356-019-04373-1
doi:

Substances chimiques

Environmental Pollutants 0
Esters 0
Phthalic Acids 0
phthalic acid 6O7F7IX66E

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

9435-9442

Subventions

Organisme : Isfahan University of Medical Sciences
ID : .

Références

PLoS One. 2013 Aug 19;8(8):e71392
pubmed: 23977034
Toxicology. 2010 May 27;271(3):73-82
pubmed: 20371260
J Clin Endocrinol Metab. 2010 Dec;95(12):5189-98
pubmed: 20829185
Sci Total Environ. 2017 Feb 1;579:606-611
pubmed: 27863867
Environ Sci Pollut Res Int. 2016 Dec;23(24):24642-24693
pubmed: 27714658
Environ Res. 2019 Feb;169:122-130
pubmed: 30447499
Sci Total Environ. 2018 Jan 15;612:1287-1292
pubmed: 28898934
Diabetes Care. 2012 Jul;35(7):1519-24
pubmed: 22498808
Ann Allergy Asthma Immunol. 2014 Jun;112(6):496-502
pubmed: 24726194
Environ Health Perspect. 2007 Jun;115(6):876-82
pubmed: 17589594
Environ Sci Pollut Res Int. 2018 Dec;25(34):34046-34052
pubmed: 30280344
Crit Rev Toxicol. 2014 Feb;44(2):151-75
pubmed: 24417397
Environ Toxicol Pharmacol. 2013 Jul;36(1):88-96
pubmed: 23603460
Metabolism. 2013 May;62(5):622-33
pubmed: 23260798
Endocrine. 2017 Mar;55(3):666-681
pubmed: 27822670
Environ Int. 2016 Jul-Aug;92-93:157-64
pubmed: 27104673
J Clin Endocrinol Metab. 2015 Jul;100(7):2640-50
pubmed: 25993640
Environ Health Perspect. 2013 Nov-Dec;121(11-12):1273-81
pubmed: 24058052
Philos Trans R Soc Lond B Biol Sci. 2009 Jul 27;364(1526):2153-66
pubmed: 19528062
Environ Res. 2015 Feb;137:419-23
pubmed: 25622280
Int J Health Plann Manage. 2014 Jul-Sep;29(3):e277-90
pubmed: 23630092
Metabolism. 2005 Feb;54(2):206-11
pubmed: 15690315
Environ Health. 2014 Feb 05;13(1):6
pubmed: 24499162
Environ Health Perspect. 2012 Sep;120(9):1307-13
pubmed: 22796563
PLoS One. 2015 Feb 23;10(2):e0117831
pubmed: 25706863
Pediatrics. 2013 Sep;132(3):e646-55
pubmed: 23958772
Hum Exp Toxicol. 2006 Jun;25(6):297-303
pubmed: 16866186
Environ Pollut. 2017 Jun;225:112-117
pubmed: 28359975

Auteurs

Bahareh Shoshtari-Yeganeh (B)

Environment Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Maryam Zarean (M)

Environment Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Marjan Mansourian (M)

Department of Biostatistics and Epidemiology, Faculty of Health, Isfahan University of Medical Sciences, Isfahan, Iran.

Roya Riahi (R)

Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Parinaz Poursafa (P)

Environment Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran. parinazpoursafa@gmail.com.

Hakimeh Teiri (H)

Environment Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Nasim Rafiei (N)

Environment Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Bahare Dehdashti (B)

Environment Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Roya Kelishadi (R)

Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH